HuagongsheHuagongshe Chemistry Print Report · For research reference only
(S)-N-[3-(3-Fluoro-4-iodo-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide → HCID 10314631, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (S)-N-[3-(3-Fluoro-4-iodo-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide | HCID 11222662 | — |
| Reactant | tert-butyl [(5S)-3-(4-iodophenyl)-2-oxo-1,3-oxazolidin-5-yl]methylcarbamate | HCID 86591790 | — |
| Product | HCID 10314631 | HCID 10314631 | — |
Reaction Steps
N-({(5S)-2-oxo-3-[4-(6-oxopiperidin-3-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)acetamide is prepared by the route described in Example 1 substituting tert-butyl [(5S)-3-(4-iodophenyl)-2-oxo-1,3-oxazolidin-5-yl]methylcarbamate for N-{[(5S)-(3-fluoro-4-iodophenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide. 1H-NMR (DMSO) δ: 8.24, 7.51, 7.47, 7.33, 4.71, 4.10, 3.72, 3.40, 3.18, 3.14, 2.97, 2.28, 1.94, 1.83
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07094900B2 |
| Source dataset | uspto-grants-2006_08 |
| ORD ID | ord-481e7c54b6434612a675d5ca6d8123d4 |
| Source note | uspto-grants-2006_08 |